Somahlution Inc - Product Pipeline Analysis, 2019 Update

Somahlution Inc - Product Pipeline Analysis, 2019 Update

Summary

Somahlution Inc (Somahlution) is a biotechnology company that offers discovery, development and commercialization of innovative solutions to advance clinical performance. The company offers duragraft, a vascular graft treatment that improves clinical outcomes by reducing the incidence and complications of graft failure. It offers research and development approach, product pipeline management, clinical trials, initiated trial and education services. Somahlution provides solutions in the areas of ischemia reperfusion injury, organ and tissue transplantation, cardiothoracic and vascular surgery and renal dialysis. The company’s products are used in ischemia reperfusion injury, coronary artery bypass surgery, PCI, peripheral vascular bypass surgery and organ transplantation applications. Somahlution is headquartered in Jupiter, Florida, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Somahlution Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Table of Contents
Somahlution Inc Company Overview
Somahlution Inc Company Snapshot
Somahlution Inc Pipeline Products and Ongoing Clinical Trials Overview
Somahlution Inc – Pipeline Analysis Overview
Somahlution Inc - Key Facts
Somahlution Inc - Major Products and Services
Somahlution Inc Pipeline Products by Development Stage
Somahlution Inc Ongoing Clinical Trials by Trial Status
Somahlution Inc Pipeline Products Overview
Duragraft
Duragraft Product Overview
Duragraft Clinical Trial
SOM-Heart
SOM-Heart Product Overview
SOM-Kidney
SOM-Kidney Product Overview
SOM-Liver
SOM-Liver Product Overview
SOM-Lung
SOM-Lung Product Overview
Somahlution Inc - Key Competitors
Somahlution Inc - Key Employees
Somahlution Inc - Locations And Subsidiaries
Head Office
Recent Developments
Somahlution Inc, Recent Developments
Feb 13, 2018: Somahlution Announces Site Initiation and Patient Enrollment in United Kingdom for European DuraGraft Registry
May 30, 2017: Somahlution Announces DuraGraft Registry Initiation at Leading Cardiac Surgery Hospitals in Germany
May 05, 2017: Somahlution Announces Medical University of Vienna as First Austrian Site to Participate in DuraGraft Registry
Feb 01, 2017: Somahlution Announces Multiple Site Initiation and Patient Enrollment in Spain for European DuraGraft Registry
Jan 04, 2017: Somahlution Announces Patient Enrollment In Duragraft CABG European Registry
Oct 04, 2016: Somahlution Announces Study Results Showing DuraGraft Vascular Graft Treatment Improves Long-Term Outcomes in Coronary Artery Bypass Grafting Surgery
Jan 06, 2016: Somahlution Announces Collaboration with Owens & Minor's Movianto Group To Provide Global Warehousing Services
Oct 29, 2015: DuraGraft Makes a Strong Impression at the EACTS Annual Meeting in Amsterdam during Satellite Symposium Featuring Dr. John R. Pepper
Sep 09, 2015: Dr. Louis Perrault Presents Design and Progression of Prospective DuraGraft Study During Recent AATS International Coronary Congress
Mar 25, 2015: Somahlution Announces New Global Distribution Partnerships For Duragraft Vascular Conduit Solution
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Somahlution Inc Pipeline Products and Ongoing Clinical Trials Overview
Somahlution Inc Pipeline Products by Equipment Type
Somahlution Inc Pipeline Products by Indication
Somahlution Inc Ongoing Clinical Trials by Trial Status
Somahlution Inc, Key Facts
Somahlution Inc, Major Products and Services
Somahlution Inc Number of Pipeline Products by Development Stage
Somahlution Inc Pipeline Products Summary by Development Stage
Somahlution Inc Ongoing Clinical Trials by Trial Status
Somahlution Inc Ongoing Clinical Trials Summary
Duragraft - Product Status
Duragraft - Product Description
Duragraft - European (EU) Multi-center Registry to Assess Outcomes in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery: Treatment of Vascular Conduits with Duragraft, a Novel Endothelial Damage Inhibitor: (VASC)
SOM-Heart - Product Status
SOM-Heart - Product Description
SOM-Kidney - Product Status
SOM-Kidney - Product Description
SOM-Liver - Product Status
SOM-Liver - Product Description
SOM-Lung - Product Status
SOM-Lung - Product Description
Somahlution Inc, Key Employees
Glossary
List of Figures
Somahlution Inc Pipeline Products by Equipment Type
Somahlution Inc Pipeline Products by Development Stage
Somahlution Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook